Anesthesia & Respiratory equipment belongs within the mountains of categories of the broader medical devices market. These medical equipment types are varied, including, among others, anesthesia machines (e.g. continuous-flow anaesthetic machines), anesthesia breathing circuits, anesthesia gas masks, CPAP(continuous positive airway pressure) devices, ventilators, nasal cannulas, bag valve masks, inhalers, and airway adjuncts.
The world Anesthesia and Respiratory Market is likely to value nearly EUR 10 billion by end-2016, with respiratory products making up the biggest category (just over 56%). The growth is anticipated to be pushed upwards primarily by the mushrooming number of patients suffering badly from chronic obstructive lung disease (COLD) and obstructive sleep apnea-hypopnea (OSAH), and also the abundance of medical items for curing these two disturbances. The Anesthesia and Respiratory Market is quite fragmented, with major participants enjoying a cumulative market share of over 49%. GE Healthcare, Philips Healthcare, Covidien plc, Getinge Group, Teleflex Inc., and Draegerwerk AG & Co. belong within the most remarkable players.
This Catalogue’s research reports focus on the Anesthesia and Respiratory Market and its motley categories, presenting comprehensive market analyses from a global sight angle and across smaller geographies. Besides covering market size figures and forecasts, the research reports review in detail the major trends, opportunities, and factors determining each market segment’s growth. The research reports also picture the competitive scene, profiling players with their competencies and strategies.
Publications found:
906
Sort by:
Smart Inhalers Market Forecasts to 2034 – Global Analysis By Product Type (Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Soft Mist Inhalers, Nebulizer-Based Smart Inhalers, Accessories & Add-On Sensors, and Other Product Types), Technology, Indication, Component, Age Group, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Smart Inhalers Market is accounted for $1.4 billion in 2026 and is expected to reach $6.2 billion by 2034, growing at a CAGR of 20.3% during the forecast perio...
June 2026
200 pages
